Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

EPOR/JAK/STAT Signaling Pathway As Therapeutic Target of Acute Erythroid Leukemia

Blood (2021) 138 (Supplement 1): 610.

https://doi.org/10.1182/blood-2021-152800

Published: 2021

Journal Articles

Genotype-Phenotype Relationships and Therapeutic Targets in Acute Erythroid Leukemia

June Takeda, MD, Kenichi Yoshida, MDPhD, Akinori Yoda, PhD, Lee-Yung Shih, MD, Yasuhito Nannya, MD PhD, Yotaro Ochi, MD, Ayana Kon, MD PhD, Kenichi Chiba, Yuichi Shiraishi, PhD, Yusuke Shiozawa, MD PhD, Tetsuichi Yoshizato, MD PhD, Cassandra M Kerr, MS, Yasunobu Nagata, MD PhD, Toshiyuki Kitano, MD PhD, Akira Hangaishi, MD PhD, Ken Ishiyama, MD PhD, Hisashi Tsurumi, MD PhD, Yasushi Miyazaki, MD PhD, Nobuhiro Hiramoto, MD, Takayuki Ishikawa, MD PhD, Masahiro Marshall Nakagawa, MDPhD, Akifumi Takaori-Kondo, MD PhD, Shigeru Chiba, MD PhD, Hideyuki Nakazawa, MD PhD, Ming-Chung Kuo, MD, Keisuke Kataoka, MD PhD, Ryunosuke Saiki, MD, Hiroko Tanaka, Kensuke Usuki, MD PhD, Shuichi Miyawaki, MD PhD, Satoru Miyano, PhD, Jaroslaw P. Maciejewski, MD PhD, Arnold Ganser, Michael Heuser, Prof., MD, Felicitas Thol, Hideki Makishima, MD PhD, Seishi Ogawa, MD PhD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-141750

Published: 2020

Journal Articles

Novel Molecular Pathogenesis and Therapeutic Target in Acute Erythroid Leukemia

Blood (2019) 134 (Supplement_1): 914.

https://doi.org/10.1182/blood-2019-129940

Published: 2019

Journal Articles

Prognostic Impact of Time from Diagnosis to Initial Chemotherapy for Acute Myeloid Leukemia

Yoshimasa Kamoda, MD, Akira Hangaishi, MD PhD, Hiroki Hayashida, MD, Yusuke Uchibori, MD, Hiromitsu Iizuka, MD PhD, Michiko Kida, MD PhD, Kensuke Usuki, MD PhD

Blood (2018) 132 (Supplement 1): 3981.

https://doi.org/10.1182/blood-2018-99-111123

Published: 2018

Journal Articles

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

Blood (2017) 130 (Supplement 1): 4127.

https://doi.org/10.1182/blood.V130.Suppl_1.4127.4127

Published: 2017

Journal Articles

Genetic Profile of Acute Erythroid Leukemia

June Takeda, MD, Kenichi Chiba, BA, Yuichi Shiraishi, PhD, Tetsuichi Yoshizato, MD PhD, Yusuke Shiozawa, MD, Yasunobu Nagata, MD, PhD, Akira Hangaishi, MD PhD, Ken Ishiyama, MD PhD, Keisuke Kataoka, MD PhD, Masashi Sanada, MD PhD, Hiroko Tanaka, BA, Kensuke Usuki, MD PhD, Shuichi Miyawaki, MD PhD, Satoru Miyano, PhD, Arnold Ganser, MD, Seishi Ogawa, MD PhD, Michael Heuser, MD, Felicitas Thol, MD, Kenichi Yoshida, MD, PhD

Blood (2016) 128 (22): 40.

https://doi.org/10.1182/blood.V128.22.40.40

Published: 2016

Journal Articles

Association of Increased Ring Ssideroblasts with Inferior Survival in Patients with Myelodysplastic Syndrome with Multi-Lineage Dysplasia

Hiroshi Kawabata, MD PhD, Kaoru Tohyama, MD PhD, Akira Matsuda, MD PhD, Kayano Araseki, MD PhD, Tomoko Hata, MD PhD, Takahiro Suzuki, MD, PhD, Hidekazu Kayano, MD PhD, Kei Shinbo, MT, Kensuke Usuki, MD PhD, Akira Hangaishi, MD PhD, Shigeru Chiba, MD, PhD, Nogawa Masaharu, MD PhD, Nobuyoshi Arima, MD PhD, Takayuki Ishikawa, MD PhD, Keiya Ozawa, MD PhD, Shunya Arai, MD, PhD, Mineo Kurokawa, MD, PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2016) 128 (22): 5530.

https://doi.org/10.1182/blood.V128.22.5530.5530

Published: 2016

Journal Articles

Sustained Molecular Response with Maintenance Dose of Interferon Alfa After Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia

Kensuke Usuki, MD, PhD, Nozomi Yusa, Akira Hangaishi, MD, PhD, Rieko Sekine, MD, PhD, Kenshi Suzuki, MD, PhD, Shinya Kimura, MD, PhD, Arinobu Tojo, MD, PhD.

Blood (2012) 120 (21): 1684.

https://doi.org/10.1182/blood.V120.21.1684.1684

Published: 2012

Journal Articles

Monitoring Trough Concentration of Voriconazole Is Important to Ensure Successful Antifungal Therapy and to Avoid Hepatic Damage in Patients with Hematological Disorders.

Yasuhito Nannya, Koki Ueda, Keiki Kumano, Akira Hangaishi, Tsuyoshi Takahashi, Yoichi Imai, Mineo Kurokawa

Blood (2009) 114 (22): 4731.

https://doi.org/10.1182/blood.V114.22.4731.4731

Published: 2009

Journal Articles

Impact On Survival and Treatment of Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.

Koki Ueda, Takeyuki Watadani, Eriko Maeda, Satoshi Ota, Keisuke Kataoka, Sachiko Seo, Keiki Kumano, Akira Hangaishi, Tsuyoshi Takahashi, Yoichi Imai, Kuni Ohtomo, Masashi Fukayama, Yasuhito Nannya, Mineo Kurokawa

Blood (2009) 114 (22): 3318.

https://doi.org/10.1182/blood.V114.22.3318.3318

Published: 2009

Journal Articles

An Extended Mathematical Model of Pathophysiology and Response to Treatment in Chronic Myelogenous Leukemia

Yasuhito Nannya, MD, PhD, Yoichi Imai, Akira Hangaishi, Mineo Kurokawa, MD, PhD

Blood (2008) 112 (11): 4220.

https://doi.org/10.1182/blood.V112.11.4220.4220

Published: 2008

Journal Articles

Relationships Between Late Viral Infections and Immune Reconstitution after Hematopoietic Stem Cell Transplantation.

Yuki Asano-Mori, MD, PhD, Yoshinobu Kanda, MD, PhD, Kumi Oshima, MD, PhD, Yasuhito Nanya, MD, PhD, Keiki Kumano, MD, PhD, Takashi Asai, MD, PhD, Akira Hangaishi, MD, PhD, Tsuyoshi Takahashi, MD, PhD, Yoichi Imai, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2008) 112 (11): 1145.

https://doi.org/10.1182/blood.V112.11.1145.1145

Published: 2008

Journal Articles

Pbx-1 Is a Direct Target of Evi-1 in Hematopoietic Stem/Progenitors and Leukemic Cells.

Munetake Shimabe, Susumu Goyama, MD, PhD, Motoshi Ichikawa, MD, PhD, Yoichi Imai, MD, PhD, Tsuyoshi Takahashi, MD, PhD, Akira Hangaishi, MD, PhD, Mineo Kurokawa, MD, PhD

Blood (2008) 112 (11): 1192.

https://doi.org/10.1182/blood.V112.11.1192.1192

Published: 2008

Journal Articles

Evi-1 Is a Direct Target of MLL Oncoproteins in Hematopoietic Stem Cells

Shunya Arai, Susumu Goyama, Munetake Shimabe, Motoshi Ichikawa, Yoichi Imai, Tsuyoshi Takahashi, Akira Hangaishi, Mineo Kurokawa, MD, PhD

Blood (2008) 112 (11): 3807.

https://doi.org/10.1182/blood.V112.11.3807.3807

Published: 2008

Journal Articles

Evi-1 Interacts with Histone Methyltransferases for Transcription Repression and Bone Marrow Transformation.

Susumu Goyama, Eriko Nitta, Munetake Shimabe, Tetsuya Yoshino, Shinichi Kako, Motoshi Ichikawa, Yoichi Imai, Tsuyoshi Takahashi, Akira Hangaishi, Mineo Kurokawa, MD, PhD

Blood (2008) 112 (11): 2257.

https://doi.org/10.1182/blood.V112.11.2257.2257

Published: 2008

Journal Articles

Long-Term Ultra-Low-Dose Acyclovir Against Varicella-Zoster Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation.

Yuki Asano-Mori, MD, Yoshinobu Kanda, M.D., PhD, Kumi Oshima, M.D., PhD, Shinichi Kako, M.D., Akihito Shinohara, M.D., Hideki Nakasone, M.D., Hiroyuki Sato, M.D., PhD, Takuro Watanabe, M.D., PhD, Noriko Hosoya, M.D., PhD, Koji Izutsu, M.D., PhD, Takashi Asai, M.D., PhD, Akira Hangaishi, M.D., PhD, Toru Motokura, M.D., PhD, Shigeru Chiba, M.D., PhD, Mineo Kurokawa, M.D., PhD

Blood (2007) 110 (11): 1967.

https://doi.org/10.1182/blood.V110.11.1967.1967

Published: 2007

Journal Articles

High-Resolution Analyses of Epigenetic Aberrations in Myelodysplastic Syndrome.

Go Yamamoto, Fumihiko Nakamura, Mitsuru Iio, Motohiro Kato, Yasuhito Nannya, Masashi Sanada14, Akira Hangaishi, Shigeru Chiba, Hiraku Mori, Mineo Kurokawa, Toshiki Watanabe, Mitsuhiro Omine, Seishi Ogawa

Blood (2007) 110 (11): 2425.

https://doi.org/10.1182/blood.V110.11.2425.2425

Published: 2007

Journal Articles

Gain-of-Function Mutations and Copy Number Increases of Notch2 in Diffuse Large B-Cell Lymphoma.

Suk Young Lee, MD, Keiki Kumano, MD, PhD, Kumi Nakazaki, MD, Masashi Sanada, MD, PhD, Go Yamamoto, MD, PhD, Yasuhito Nannya, MD, PhD, Ritsuro Suzuki, MD, PhD, Satoshi Ota, MD, PhD, Yasunori Ota, MD, PhD, Koji Izutsu, MD, PhD, Mamiko Sakata-Yanagimoto, MD, PhD, Akira Hangaishi, MD, PhD, Hideo Yagita, PhD, Masashi Fukayama, MD, PhD, Masao Seto, MD, PhD, Mineo Kurokawa, MD, PhD, Seishi Ogawa, MD, PhD, Shigeru Chiba, MD, PhD

Blood (2007) 110 (11): 695.

https://doi.org/10.1182/blood.V110.11.695.695

Published: 2007

Journal Articles

Empiric or Presumptive Anti-Aspergillus Treatments for Allogeneic Hematopoietic Stem Cell Transplant Recipients with Sustained Febrile Neutropenia.

Kumi Oshima, MD, PhD, Yoshinobu Kanda, M.D.,Ph.D., Yuki Asano-Mori, M.D., Hiroyuki Sato, M.D.,Ph.D., Takuro Watabane, M.D.,Ph.D., Noriko Hosoya, M.D.,Ph.D., Koji Izutsu, M.D.,Ph.D., Takashi Asai, M.D.,Ph.D., Akira Hangaishi, M.D.,Ph.D., Toru Motokura, M.D.,Ph.D., Shigeru Chiba, M.D.,Ph.D., Mineo Kurokawa, M.D.,Ph.D.

Blood (2006) 108 (11): 5288.

https://doi.org/10.1182/blood.V108.11.5288.5288

Published: 2006

Journal Articles

Genome-Wide Analysis of Copy Number Alterations/LOH/Allelic Imbalances in Non-Hodgkin Lymphoma Using Ultrahigh-Density SNP-Genotyping Microarrays with the Robust CNAG Algorithms.

Kumi Nakazaki, MD, Yasuhito Nannya, MD, PhD, Masashi Sanada, MD, Go Yamamoto, MD, PhD, Chiaki Aoyama, MD, Fumihiko Nakamura, MD, Noriko Hosoya, MD, PhD, Lili Wang, MD, PhD, Akira Hangaishi, MD, PhD, Mineo Kurokawa, MD, PhD, Shigeru Chiba, MD, PhD, Seishi Ogawa, MD, PhD

Blood (2005) 106 (11): 420.

https://doi.org/10.1182/blood.V106.11.420.420

Published: 2005

NARROW

EPOR/JAK/STAT Signaling Pathway As Therapeutic Target of Acute Erythroid Leukemia

Genotype-Phenotype Relationships and Therapeutic Targets in Acute Erythroid Leukemia

Novel Molecular Pathogenesis and Therapeutic Target in Acute Erythroid Leukemia

Prognostic Impact of Time from Diagnosis to Initial Chemotherapy for Acute Myeloid Leukemia

Randomized Phase II Study of R-CHOP-14 Versus R-CHOP-14 Followed By Chaser As Induction Therapy for High-Dose Chemotherapy (HDT), LEED, and Autologous Stem-Cell Transplantation (ASCT) in Poor-Risk Diffuse Large B-Cell Lymphoma (DLBCL): Japan Clinical Oncology Group (JCOG) Study (JCOG0908)

Genetic Profile of Acute Erythroid Leukemia

Association of Increased Ring Ssideroblasts with Inferior Survival in Patients with Myelodysplastic Syndrome with Multi-Lineage Dysplasia

Sustained Molecular Response with Maintenance Dose of Interferon Alfa After Imatinib Discontinuation in Patients with Chronic Myeloid Leukemia

Monitoring Trough Concentration of Voriconazole Is Important to Ensure Successful Antifungal Therapy and to Avoid Hepatic Damage in Patients with Hematological Disorders.

Impact On Survival and Treatment of Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation.

An Extended Mathematical Model of Pathophysiology and Response to Treatment in Chronic Myelogenous Leukemia

Relationships Between Late Viral Infections and Immune Reconstitution after Hematopoietic Stem Cell Transplantation.

Pbx-1 Is a Direct Target of Evi-1 in Hematopoietic Stem/Progenitors and Leukemic Cells.

Evi-1 Is a Direct Target of MLL Oncoproteins in Hematopoietic Stem Cells

Evi-1 Interacts with Histone Methyltransferases for Transcription Repression and Bone Marrow Transformation.

Long-Term Ultra-Low-Dose Acyclovir Against Varicella-Zoster Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation.

High-Resolution Analyses of Epigenetic Aberrations in Myelodysplastic Syndrome.

Gain-of-Function Mutations and Copy Number Increases of Notch2 in Diffuse Large B-Cell Lymphoma.

Empiric or Presumptive Anti-Aspergillus Treatments for Allogeneic Hematopoietic Stem Cell Transplant Recipients with Sustained Febrile Neutropenia.

Genome-Wide Analysis of Copy Number Alterations/LOH/Allelic Imbalances in Non-Hodgkin Lymphoma Using Ultrahigh-Density SNP-Genotyping Microarrays with the Robust CNAG Algorithms.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only